Table 3.
Response to vaccination of beef heifers receiving saline solution (Saline; n = 14) or bovine appeasing substance (BAS; n = 15).
| Items 1 | Treatments | SEM | p-Value | ||
|---|---|---|---|---|---|
| Saline | BAS | Treatment | Treatment × Day | ||
| IBR | |||||
| Titers, log2 | <0.01 | 0.03 | |||
| d 0 | 0.00 | 0.00 | 0.35 | ||
| d 15 | 1.50 a | 3.17 b | 0.35 | ||
| d 45 | 2.17 a | 3.84 b | 0.35 | ||
| Seroconversion, % total | 0.12 | 0.09 | |||
| d 0 | 0.00 | 0.00 | 8.60 | ||
| d 15 | 66.7 x | 100 y | 8.60 | ||
| d 45 | 100 | 100 | 8.60 | ||
| PI3 | |||||
| Titers, log2 | 0.10 | 0.09 | |||
| d 0 | 0.32 | 0.57 | 0.41 | ||
| d 15 | 3.59 | 4.50 | 0.41 | ||
| d 45 | 2.87 x | 4.67 y | 0.41 | ||
| Seroconversion, % total | 75.0 | 100 | 13.0 | 0.21 | 0.34 |
1 On d 0, before treatment administration, heifers were vaccinated against infectious bovine rhinotracheitis (IBR), parainfluenza-3 (PI3) virus, bovine viral diarrhea virus type 1 and 2 (BVDV-1 and 2; 2 mL s.c.; Biopoligen HS; Biogenesis Bago SA, Buenos Aires, Argentina); x–y Within a row, without a common superscript tends to differ (p ≤ 0.10). a,b Within a row, without a common superscript differ (p ≤ 0.05).